Dr. Staddon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
230 W Washington Sq
2nd Floor
Philadelphia, PA 19106Phone+1 215-829-6088Fax+1 215-829-6104- Is this information wrong?
Education & Training
- University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1977 - 1980
- University of Pennsylvania Health SystemResidency, Internal Medicine, 1972 - 1975
- Perelman School of Medicine at the University of PennsylvaniaClass of 1972
Certifications & Licensure
- PA State Medical License 1973 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2013-2014
- Philadelphia Magazine Castle Connolly, 2008, 2011-2014
- America's Top Doctors for Cancer Castle Connolly, 2012-2013
- Join now to see all
Clinical Trials
- Safety Study of PLX108-01 in Patients With Solid Tumors Start of enrollment: 2009 Oct 01
- Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma Start of enrollment: 2011 May 01
- Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma Start of enrollment: 2011 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 17 citationsMulti-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: High rates of local control with favorable toxicity.Brian C. Baumann, Karen De Amorim Bernstein, Thomas F. DeLaney, Charles B. Simone, James D. Kolker, Edwin Choy, William P. Levin, Kristy L. Weber, Ashok Muniappan, Abi...> ;Journal of Surgical Oncology. 2020 Jun 25
- 16 citationsResults of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the Lung.Kristin Baird, John Glod, Seth M. Steinberg, Denise K. Reinke, Joseph G. Pressey, Leo Mascarenhas, Noah Federman, Neyssa Marina, Sant P. Chawla, Joanne Lagmay, John M....> ;Sarcoma. 2020 Apr 30
- 41 citationsResults of a prospective phase 2 study of pazopanib in patients with surgically unresectable or metastatic chondrosarcomaWarren Chow, Paul Frankel, Chris Ruel, Dejka M. Araujo, Mohammed M. Milhem, Scott H. Okuno, Lee Hartner, Samir D. Undevia, Arthur P. Staddon> ;Cancer. 2020 Jan 1
- Join now to see all
Hospital Affiliations
- Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania
- Pennsylvania HospitalPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: